Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy

ConclusionTorasemide treatment has benefits against adverse cardiac remodeling in CHF rats, which was better than the protection offered by spironolactone.This article is protected by copyright. All rights reserved.

Source: Cardiovascular Therapeutics - June 30, 2017 Category: Cardiology Authors: Somasundaram Arumugam, Remya Sreedhar, Vengadeshprabhu Karuppagounder, Meilei Harima, Masahiko Nakamura, Hiroshi Suzuki, Hirohito Sone, Kenichi Watanabe Tags: Original Research Article Source Type: research